𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Model for end-stage liver disease

✍ Scribed by G.E. Jung; J. Encke; J. Schmidt; A. Rahmel

Publisher
Springer
Year
2008
Tongue
German
Weight
432 KB
Volume
79
Category
Article
ISSN
0009-4722

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The model for end-stage liver disease (M
The model for end-stage liver disease (MELD)
✍ Patrick S. Kamath; W. Ray Kim πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 153 KB πŸ‘ 1 views

The Model for End-stage Liver Disease (MELD) was initially created to predict survival in patients with complications of portal hypertension undergoing elective placement of transjugular intrahepatic portosystemic shunts. The MELD which uses only objective variables was validated subsequently as an

Clinically relevant differences in the M
Clinically relevant differences in the Model for End-Stage Liver Disease and Model for End-Stage Liver Disease–sodium scores
✍ Rhiana Garritsen; Andrei Tintu; Herold Metselaar; Geert Kazemier πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 38 KB πŸ‘ 1 views

With interest, we read the article by Xiol et al. 1 regarding differences in serum measurements between different laboratories and their influence on the Model for End-Stage Liver Disease (MELD) and the Model for End-Stage Liver Disease incorporating serum sodium (MELD-Na). They reported significant

Reply: Clinically relevant differences i
Reply: Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease–sodium scores
✍ Xavier Xiol; Jose Castellote; Xavier Fuentes-Arderiu πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 37 KB πŸ‘ 1 views

We thank Garritsen et al. 1 for their interest in our article about differences in Model for End-Stage Liver Disease (MELD) and Model for End-Stage Liver Disease-Sodium (MELD-Na) scores determined at 3 different laboratories. 2 We agree that one of the important messages of our article is the import

Model for end-stage liver disease (MELD)
Model for end-stage liver disease (MELD) exception for polycystic liver disease
✍ Luis Arrazola; Dilip Moonka; Robert G. Gish; Gregory T. Everson πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 60 KB

Polycystic liver disease (PLD) is commonly associated with polycystic kidney disease, but is unaccompanied by renal cysts in 10% of cases. Symptomatic PLD is mainly limited to adults and rarely, if ever, presents in childhood. There is currently no effective medical therapy for PLD. Most patients wh